[1] 曾飒,关永源,刘德育,等.人参皂苷Rd C12 差向异构体的合成及其对大鼠主动脉环收缩反应的影响[J].中国药理学通报,2003,19(3):282-286. [2] Shi Q, Hao Q, Bouissac J, et al. Ginsenoside-Rd from Panaxnotoginseng enhances astrocyte differentiation from neural stem cells[J]. Life Sci, 2005, 76(9):983-995. [3] Zhou JG, Qiu QY, Zhang Z, et al. Evidence for capacitative and non-capacitative Ca2+ entry pathways coexist in A10 vascular smooth muscle cells[J]. Life Sci, 2006, 78(14):1558-1563. [4] Yokozawa T, Satoh A, ChoEJ. Ginsenoside-Rd attenuates oxidative damage related to aging in senescence-accelerated mice [J].J Pharm Pharmacol, 2004, 56(1):107-113. [5] Yang Z, Chen A, Sun H, et al. Ginsenoside Rd elicits Th1 and Thimmune responses to ovalbumin in mice[J]. Vaccine, 2007, 25(1):161-169. [6] Chang T L, Ding HY, KaoY W. Role of ginsenoside Rd in inhibiting26S proteasome activity[J]. J Agric Food Chem, 2008, 56(24):12011-12015. [7]《药物遗传毒性研究技术指导原则》课题研究组.[ZH]GPT2-1,药物遗传毒性研究技术指导原则[S].国家食品药品监督管理局药品审评中心,2007:26-28. [8] 袁伯俊,廖明阳,李波.药物毒理学试验方法与技术[M].第1 版.北京:化学工业出版社,2007,268-269. [9] 盛卸晃,刘妹,刘兆平.PT-141 染色体畸变试验[J].毒理学杂志,2007,21(4):326-327. [10] 刘丹卓,尤昭玲,赵新广.通络丹对CHL 细胞株染色体畸变影响的研究[J].光明中医,2009,24(11):2090:2092. [11] 周超群,周珮.人参皂苷Rd 的研究进展[J].中草药,2009,40(5):832-836. |